Chemomab Therapeutics Ltd. (CMMB:NASDAQ) jumped higher at $1.28, representing a gain of 28%. The stock got featured on our News Catalysts scanner on Mon, Jun 26, 2023 at 07:18 AM in the 'BIOTECH' category. From Mon, Jun 12, 2023, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Tue, Jan 03, 2023 at $5.35 with a volume of 23M+.
About Chemomab Therapeutics Ltd. (CMMB:NASDAQ)
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need.
Top 10 Gainers:
- Trxade Group, Inc. (MEDS:NASDAQ), 93.84%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 81.36%
- MoonLake Immunotherapeutics Com (MLTX:NASDAQ), 77.55%
- Spark Networks SE (LOV:NASDAQ), 50.04%
- iMedia Brands, Inc. (IMBI:NASDAQ), 35.71%
- ACELYRIN INC. (SLRN:NASDAQ), 35.41%
- Shengfeng Development Limited (SFWL:NASDAQ), 33.2%
- Adagene Inc. (ADAG:NASDAQ), 30.37%
- Chemomab Therapeutics Ltd. (CMMB:NASDAQ), 28%
- Pharvaris N.V. (PHVS:NASDAQ), 27.76%